The relationship between inflammation and venous thrombosis is not well understood. An
inflammatory response may be both the cause and consequence of venous …

Pulmonary arterial hypertension (PAH), also known as Group 1 Pulmonary Hypertension
(PH), is a PH subset characterized by pulmonary vascular remodeling and pulmonary …

Abstract Background Soluble P‐selectin (sP‐selectin) has been proposed as a potential
biomarker for venous thromboembolism (VTE) diagnosis with interesting results. However …

Introduction. Acute pulmonary embolism (APE) is a clinical syndrome of pulmonary
circulation disorder caused by obstruction of the pulmonary artery or its branches. Histone …

Pulmonary arterial hypertension (PAH) is a rare subtype of group 1 pulmonary hypertension
(PH) diseases, characterized by high pulmonary artery pressure leading to right ventricular …

An increasing number of studies have suggested that oxidative stress and inflammation play
momentous roles in acute pulmonary embolism (APE). Honokiol, a bioactive biphenolic …

Pulmonary embolism (PE) is a potentially life-threatening condition requiring prompt
diagnosis and treatment. Recent advances have led to the development of newer …

The Emergency Heart Failure Mortality Risk Grade (EHMRG) can predict short-term mortality
in patients admitted for acute heart failure (AHF) in the emergency department (ED). This …

Pulmonary embolism (PE) and deep vein thrombosis are the main clinical manifestations of
venous thromboembolism (VTE). Acute PE is the third most common acute cardiovascular …

La enfermedad tromboembólica venosa (ETV) es una enfermedad crónica, siendo la tercera
causa de enfermedad vascular después de la cardiopatía isquémica y la enfermedad …